| Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. | |
| | |
MedLine Citation:
|
PMID: 8948386 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To evaluate the long-term effects oat bran concentrate bread products in the diet of free-living subjects with non-insulin-dependent diabetes (NIDDM) via dietary, clinical, and biochemical methods. DESIGN: A 24-week crossover study consisting of two 12-week periods. SUBJECTS/SETTING: Eight men with NIDDM (mean age = 45 years) who lived in the community. Glucose and insulin profiles were conducted in a clinical investigation unit. INTERVENTION: Palatable, high-fiber, oat bran concentrate (soluble fiber [beta-glucan] content = 22.8%) bread products were developed. Four randomly chosen subjects ate oat bran concentrate breads first; the other subjects ate control white bread first. MAIN OUTCOME MEASURES: Dietary intake (four 48-hour dietary recalls per period) was assessed. Blood glucose and insulin (8-hour profiles) and lipid parameters after fasting were measured (at 0, 12, and 24 weeks). STATISTICAL ANALYSES PERFORMED: Analysis of variance and repeated-measures analysis of variance. RESULTS: Total energy and macronutrient intakes were similar in both periods. Mean total dietary fiber intake was 19 g/day in the white bread period and 34 g/day (9 g soluble fiber per day from oat bran concentrate) in the oat bran concentrate period. Body weight remained stable. Mean glycemic and insulin response areas (area under the curve) were lower (P < or = .05 and not significant, respectively) for the oat bran concentrate period than the white bread period. After breakfast, area under the curve for the oat bran concentrate period was lower for glucose (P < or = .01) and insulin (P < or = .05); insulin peak was reached earlier (P < or = .05) than in the white bread period. Dietary fiber intake was correlated negatively with insulin area under the curve (P < or = .05). Mean total plasma cholesterol and low-density lipoprotein cholesterol levels were lower (P < or = .01) in the oat bran concentrate period than in the white bread period. In the oat bran concentrate period, the mean ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol was reduced by 24% (P < or = .05). CONCLUSIONS: The well-accepted oat bran concentrate bread products improved glycemic, insulinemic, and lipidemic responses. |
| | |
Authors:
|
M E Pick; Z J Hawrysh; M I Gee; E Toth; M L Garg; R T Hardin |
Related Documents
:
|
1816976 - Circadian variation of basal and postprandial insulin sensitivity in healthy individual... 14512036 - Metabolic effects of an enteral nutrition formula for diabetes: comparison with standar... 17524176 - Associations between postprandial insulin and blood glucose responses, appetite sensati... 12566136 - High-complex carbohydrate or lente carbohydrate foods? 913926 - Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide. 15289656 - Protein tyrosine phosphatases: potential role in beta-cell insulin signal transduction. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Journal of the American Dietetic Association Volume: 96 ISSN: 0002-8223 ISO Abbreviation: J Am Diet Assoc Publication Date: 1996 Dec |
Date Detail:
|
Created Date: 1996-12-26 Completed Date: 1996-12-26 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7503061 Medline TA: J Am Diet Assoc Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1254-61 Citation Subset: AIM; IM |
Affiliation:
|
Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Area Under Curve Avena sativa* Blood Glucose / analysis Bread* Cholesterol / blood Cholesterol, HDL / blood Cholesterol, LDL / blood Cross-Over Studies Diabetes Mellitus, Type 2 / diet therapy* Dietary Fiber / administration & dosage, therapeutic use* Eating Humans Insulin / blood Male Middle Aged Pilot Projects |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 11061-68-0/Insulin; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of qualitative and quantitative methods to define behavioral fat-reduction strategies and their ...
Next Document: Nutrient intake and obesity in prepubescent children with Down syndrome.